Epilepsia Open

Papers
(The H4-Index of Epilepsia Open is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy78
Alterations of apparent diffusion coefficient from ultra high b‐values in the bilateral thalamus and striatum in MRI‐negative drug‐resistant epilepsy59
Risk of COVID‐19 infection and seizure exacerbation among patients with epilepsy during the peak of Omicron wave46
A companion to the preclinical common data elements for proteomics, lipidomics, and metabolomics data in rodent epilepsy models. A report of the TASK3‐WG4 omics working group of the ILAE/AES joint tra45
An interview with Ifrah Zawar, 2023 Epilepsia Open prize winner for clinical research39
Evaluation of the International League Against Epilepsy 1981, 1989, and 2017 classifications of seizure semiology and etiology in a population‐based cohort of children and adults with epilepsy39
Commentary on “The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia”35
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients30
Patient complexity, depression, and quality of life in patients with epilepsy at an epilepsy center in Japan27
Key steps and barriers in the journey of patients with epilepsy through the National Healthcare System in Spain: The EPIPASS qualitative study26
Microglia and status epilepticus in the immature brain25
Clinical characteristics and outcomes after new‐onset seizure among Zambian children with HIV during the antiretroviral therapy era22
Total posterior quadrant disconnection for drug‐resistant epilepsy in children22
Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first‐line add‐on therapies for seizures in Dravet syndrome: A network meta‐analysis21
Intestinal microbiome alterations in pediatric epilepsy: Implications for seizures and therapeutic approaches20
Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy20
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges19
One‐year seizure freedom and quality of life in patients with drug‐resistant epilepsy receiving adjunctive vagus nerve stimulation in Japan18
Longitudinal hippocampal diffusion‐weighted imaging and T2 relaxometry demonstrate regional abnormalities which are stable and predict subfield pathology in temporal lobe epilepsy18
0.17330384254456